Immune reconstitution following T-cell depleted bone marrow transplantation: Effect of age and posttransplant graft rejection prophylaxis

Biology of Blood and Marrow Transplantation

Volumn 3, Issue 2, 1997, Pages 65-75

  Small, Trudy N ^a   Avigan, David ^a   Dupont, Bo ^a   Smith, Kathy ^a   Black, Pat ^a   Heller, Glenn ^a   Polyak, Tatyana ^a   O'Reilly, Richard J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

ATG; BMT; Immune reconstitution; Infection

Indexed keywords

ADOLESCENT; ADULT; AGING; ARTICLE; BONE MARROW TRANSPLANTATION; CASE CONTROL STUDY; CHILD; CYTOLOGY; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOLOGY; INFANT; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MALE; MIDDLE AGED; PRESCHOOL CHILD; RISK FACTOR; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGING; BONE MARROW TRANSPLANTATION; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT REJECTION; HUMANS; INFANT; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MALE; MIDDLE AGED; RISK FACTORS; T-LYMPHOCYTES;

EID: 0031157726     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Chao NJ, Forman SJ, Schmidt GM, Snyder DS, Amylon MD, Konrad PN, Nademanee AP, O'Donnell MR, Parker PM, Stein AS, Smith E, Wong RM, Hoffe RT, Blume KG: Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission. Blood 78:1923, 1991.
2. Copelan EA, Biggs JC, Thompson JM, Crilley P, Szer J, Klein JP, Kapoor N, Avalos BR, Cunningham I, Atkinson K, Downs K, Harmon GS, Daly MB, Brodsky I, Bulova SI, Tutschka PJ: Treatment for acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2. Blood 78:838, 1991.
3. Blaise D, Maraninchi D, Archimbaud E, Reiffers J, Devergie A, Jouet JP, Milpied N, Attal M, Michelle M, Ifrah N, Kuentz M, Dauriac C, Bordigoni P, Gratecos N, Guilhot F, Guyotat D, Gouvernet J, Gluckman E: Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: A randomized trial of a Busulfan-Cytoxan versus Cytoxan-Total Body Irradiation as Preparative Regimen: A report from the Groupe d'Etudes de la Greffe de Moelle Osseuse. Blood 79:2578, 1992.
4. Snyder DS, Chao NJ, Amylon MD, Taguchi J, Long GD, Neigin RS, Nademanee AP, O'Donnell MR, Schmidt GM, Stein AS, Parker PM, Smith EP, Stepan DE, Molin A, Lipsett JA, Hoppe RT, Niland JC, Dagis AC, Wong RM, Forman SJ, Blume KG: Fractionated total body irradiation and high dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission. Blood 82:2920, 1993.
5. Clift RA, Buckner CD, Thomas ED, Bensinger WI, Bowden R, Bryant E, Deeg HJ, Doney KC, Fisher LD, Hansen JA, Martin P, McDonald GB, Sanders JE, Schoch G, Singer J, Storb R, Sullivan KM, Witherspoon RP, Appelbaum FR: Marrow transplantation for chronic myeloid leukemia: A randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood 84:2036, 1994.
6. Marks DI, Cullis JO, Ward KN, Lacey S, Zydlo R, Hughes TP, Schwarer AP, Lutz E, Barrett AJ, Hows JM, Batchelor JR, Goldman JM: Allogeneic bone marrow transplantation for chronic myelogenous leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years. Ann Intern Med 119:207, 1993.
7. Parkman R: Immunological Reconstitution, in SJ Forman, KG Blume and ED Thomas (eds): Bone Marrow Transplantation. Boston, MA, Blackwell Scientific Publications, p. 504, 1994.
8. Lum, LG: The kinetics of immune reconstitution after human marrow transplantation. Blood 69:369, 1987.
9. Ochs L, Shu XO, Miller J, Enright H, Wagner J, Filipovich A, Miller W, Weisdorf D: Late infections after allogeneic bone marrow transplantation: Comparison of incidence in related and unrelated donor transplant recipients. Blood 86:3979, 1995.
10. Neiman PE, Reeves W, Ray G, Flournoy N, Lerner KG, Sale GE, Thomas ED: A prospective analysis of interstitial pneumonia and opportunistic viral infection among recipients of allogeneic bone marrow grafts. J Infect Dis 136:754, 1977.
11. Atkinson K, Farewell V, Storb R, Ysoi M-S, Sullivan KM, Witherspoon RP, Fefer A, Clift R, Goodell B, Thomas ED: Analysis of late infections after human bone marrow transplantation: Role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease. Blood 60:714, 1982.
12. Sullivan KM, Witherspoon RP, Storb R, Weiden P, Fluornoy N, Dalhlberg S, Deeg HJ, Saunders JE, Doney KC, Appelbaum FR, McGuffin R, McDonald GB, Meyers J, Schubert MM, Gauvreau J, Shulman HM, Sale GE, Anasetti C, Loughran TP, Strom S, Nims J, Thomas ED: Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: Prognostic influence of thrombocytopenia after allogeneic marrow transplantation. Blood 72:546, 1988.
13. Sullivan KM, Witherspoon RP, Storb R, Deeg HJ, Dahlberg S, Sanders JE, Appelbaum FR, Doney KC, Weiden P, Anasetti C, Loughran TP, Hill R, Shields A, Yee G, Shulman H, Nims J, Strom S, Thomas ED: Alternating-day Cyclosporine A and prednisone for the treatment of high-risk chronic graft-v-host disease. Blood 72:555, 1988.
14. O'Donnell MR, Schmidt GM, Tegtmeier BR, Faucett C, Fahey JL, Ito J, Nademanee A, Niland J, Parker P, Smith EP, Snyder DS, Stein AS, Blume KG, Forman SJ: Predictions of systemic fungal infection in allogeneic marrow recipients: Impact of amphotericin prophylaxis in high-risk patients. J Clin Oncol 12:827, 1994.
15. Meyers JD, Flournoy N, Thomas ED: Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 153:478, 1986.
16. Miller W, Flynn P, McCullough J, Balfour HH Jr., Goldman A, Haake R, McGlave P, Ramsay N, Kersey J: Cytomegalovirus infection after bone marrow transplantation: An association with acute graft-v-host disease. Blood 67:1162, 1986.
17. Kernan N: T-cell depletion for prevention of graft-versus-host disease, in SJ Forman, KG Blume and ED Thomas (eds): Bone Marrow Transplantation. Boston, MA, Blackwell Scientific Publications, p. 124, 1994.
18. Keever CA, Small TN, Flomenberg N, Heller G, Pekle K, Black P, Kernan NA, O'Reilly RJ: Immune reconstitution following bone marrow transplantation: Comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood 73:1340, 1989.
19. Foot ABM, Potter MN, Donaldson C, Cornish JM, Wallington TB, Oakhill A, Pamphilon DH: Immune reconstitution after BMT in children. Bone Marrow Transpl 11:7, 1993.
20. Kernan NA, Bordignon C, Heller G: Graft failure following T-cell depleted HLA-identical marrow transplants for leukemia: Analysis of risk factors and results of secondary transplants. Blood 74:2227, 1989.
21. Reisner Y, Kapoor N, Kirkpatrick D, Pollack D, Dupont B, Good RA, O'Reilly RJ: Transplantation for acute leukaemia with HLA-A and B non-identical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells. Lancet 31:327, 1981.
22. Buffone G, Savory J, Cross RE, Hammond JE: Evaluation of kinetic light scattering as an approach to the measurement of specific proteins with the centrifugal analyzer. I. Methodology. Clin Chem 21:1731, 1977.
23. Tietz, NW: Clinical Guide to Laboratory Tests. Philadelphia, PA, W.B Saunders Company, 1990.
24. Armitage P, Berry G: Statistical Methods in Medical Research. Boston, MA, Blackwell Scientific Publications, 1994.
25. Zeger SL, Linag KY: Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42:121, 1986.
26. Prentice RL, Kalbfleisch JD, Peterson AV, Flournoy N, Farewell VT, Breslow NE: The analysis of failure times in the presence of competing risks. Biometrics 34:541, 1978.
27. Bordignon C, Keever CA, Small T, Dupont B, O'Reilly RJ, Kernan NA: Graft failure following T-cell depleted HLA-identical marrow transplants for leukemia: In vitro analyses of host effector mechanisms. Blood 74:2237, 1989.
28. -) BMTs from HLA-identical siblings. Blood 86:621a, 1995 (abstract).
29. + subsets after allogeneic bone marrow transplantation in man. Scand J Immunol 33:499, 1991.
30. + cells of naive and memory phenotype in bone marrow transplant recipients. Transpl Proc 23:165, 1991.
31. Storek J, Witherspoon RP, Storb R: T-cell reconstitution after bone marrow transplantation into adult patients does not resemble T-cell development in early life. Bone Marrow Transplant 16:3:413, 1995.
32. Sugita K, Soiffer RJ, Murray C, Schlossman SF, Ritz J, Morimota C: The phenotype and reconstitution of immunoregulatory T-cell subsets after T-cell depleted allogeneic and autologous bone marrow transplantation. Transplantation 57:1465, 1994.
33. Brooks EG, Schmalstieg FC, Wirt DP, Rosenblatt HM, Adkins LT, Lookingbill DP, Rudloff HE, Rakusan TA, Goldman AS: A novel X-linked combined immunodeficiency disease. J Clin Invest 86:1623, 1990.
34. + T lymphocytes in common variable immunodeficiency. Blood 323:276, 1990.
35. +) in patients after bone marrow transplantation. Transplantation 44:381, 1987.
36. + lymphocytes and T-cell dysfunction in recipients of bone marrow transplantation. Clin Exp Immunol 82:145, 1990.
37. + cells in patients with graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transpl 13:181, 1994.
38. + T lymphocytes from patients suffering from AIDS and immunosuppressed bone marrow recipients. J Exp Med:2882, 1994.
39. + cells in acquired immune deficiency syndrome (AIDS), AIDS-related complex, and asymptomatic homosexuals. J Clin Immunol 6:502, 1986.
40. + cells in normal, healthy individuals: Correlations with human cytomegalovirus (HCMV) carrier status, phenotypic and functional analyses. Clin Exp Immunol 94:297, 1993.
41. + T cells define a unique subset of patients with common variable immunodeficiency. Blood 82:192, 1993.
42. + T cells from HIV-infected subjects. Clin Exp Immunol 100:425, 1995.
43. Azuma M, Phillip JH, Lanier LL: CD28- T lymphocytes. Antigenic and functional properties. J Immunol 150:1147, 1993.
44. Morimoto C, Letvin NL, Distaso JA, Aldrich WR, Schlossman SF: The isolation and characterization of the human suppressor inducer T-cell subset. J Immunol 134:1508, 1985.
45. +) T cells in normal, healthy individuals specifically suppress the generation of cytotoxic T lymphocytes to Epstein-Barr virus-transformed B cell lines. Eur J Immunol 24:2903, 1994.
46. + lymphocytes from bone marrow transplanted patients inhibits cell-mediated cytolysis. Blood 77:2237, 1991.
47. Soiffer RJ, Bosserman K, Murray C, Cochran K, Daley J, Ritz J: Reconstitution of T-cell function after CD6-depleted allogeneic bone marrow transplantation. Blood 75:2076, 1990.
48. Janossy G, Prentice HG, Grob J-P, Ivory K, Tidman N, Grundy J, Favrot M, Brenner MK, Campana D, Blacklock HA, Gilmore MJML, Patterson J, Griffiths PD, Hoffbrand AV: T lymphocyte regeneration after T-cell depleted allogeneic bone marrow. Clin Exp Immunol 63:577, 1986.
49. Parreira A, Smith J, Hows JM, Smithers SA, Apperley J, Rombos Y, Goldman JM, Gordon-Smith EC, Catovsky D: Immunological reconstitution after bone marrow transplant with Campath-I treated bone marrow. Clin Exp Immunol 67:142, 1987.
50. Small TN, Keever CA, Weiner-Fedus S, Heller G, O'Reilly RJ, Flomenberg N: B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: A recapitulation of normal B-cell ontogeny. Blood 76:1647, 1990.
51. Storek J, Saxon A: Reconstitution of B cell immunity following bone marrow transplantation. Bone Marrow Transplantation 9:395, 1992.
52. + T lymphocytes. Immunol Today 9:367, 1988.
53. Guinan EC, Gribben JG, Boussiotis VA, Freeman G, Nadler NM: Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. Blood 84:3261, 1996.
54. Erkeller-Yuksel FM, Deneys V, Yujsel B, Hannet I, Hulstaert F, Hamilton H, Stokes LT, Munhyeshuli V, Vanlangendonck F, De Bruyere M, Bach BA, Ludyard PM: Age-related changes in human blood lymphocyte subpopulations. J Pediatr 120:216, 1992.
55. + T cells. J Immunol 151:2237, 1993.
56. Mackall CL, Granger L, Sheard MA, Cepeda R, Gress RE: T-cell regeneration after bone marrow transplantation: Differential CD45 isoform expression on thymic-derived versus thymic-independent progeny. Blood 82:2585, 1993.
57. Weiberg K, Annett G, Kashyap A, Lenarsky C, Forman SJ, Parkman R: The effect of thymic function on immunocompetence following bone marrow transplantation. Biol Blood and Marrow Transplant 1:18, 1995.
58. + T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 332:143, 1995.
59. + T lymphocytes at diagnosis of Acquired Immunodeficiency Syndrome-defining and other human immunodeficiency virus-related illnesses. Arch Intern Med 155:1537, 1995.
60. Crow SM, Carlin JB, Stewart KI, Lucas CR, Hoy JF: Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. Journal of Acquired Immunodeficiency Syndromes 4:770, 1991.
61. -) bone marrow allograft recipients for acute non-lymphocytic leukemia in first remission. Blood 84:1309a, 1994 (abstract).
62. Papadopoulos EB, Ladanyi M, Emanuel D, Mackinnon S, Rosenfield NS, Lieberman PH, Collins NH, Boulad F, Carabasi MH, Castro-Malaspina H, Childs BH, Gillio AP, Small TN, Young JW, Kurtz RM, Kernan NA, O'Reilly RJ: Infusions of donor leukocytes as treatment of Epstein-Barr virus associated lymphoproliferative disorders complicating allogeneic marrow transplantation. N Engl J Med 330:1185, 1994.
63. Papadopoulos EB, Small T, Ladanyi M, Boulad F, Castro-Mataspina H, Childs B, Kernan N, Mackinnon S, Szabolcs P, Small TN, Young J, O'Reilly RJ: Current results of donor leukocyte infusions for treatment of Epstein-Barr virus-associated lymphoproliferative disorders following related and unrelated T-cell depleted bone marrow transplant. Blood 88 (suppl 1):681a, 1996.
64. Small T, Boulad F, Kernan N, Szabolcs P, Van Syckle K, Papadopoulos E, Black P, Taylor J, Childs B, Young J, Castro-Malaspina A, Jakubowski A, O'Reilly RJ: Analysis of opportunistic infections in 423 patients following allogeneic unmodified or T-cell depleted related or unrelated bone marrow transplantation. Blood 88 (suppl 1):427a, 1996.